U.S. Congress - S.1088 Lower PRICED Drugs Act
S.1088 - Lower PRICED Drugs Act
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes. view all titles (3)
All Bill Titles
- Short: Lower PRICED Drugs Act as introduced.
- Short: Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act as introduced.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes. as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 1
- Past Seven Days: 8
- All-Time: 1,204
|
|
|
|
|
|
|
|
Official Summary
4/11/2007--Introduced.Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act or the Lower PRICED Drugs Act - Amends the Federal Food, Drug, and Cosmetic Act to require an abbreviated application for a new drug containing certain antibiotics, the approved labOfficial Summary
4/11/2007--Introduced.Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act or the Lower PRICED Drugs Act - Amends the Federal Food, Drug, and Cosmetic Act to require an abbreviated application for a new drug containing certain antibiotics, the approved labeling for which includes a method of use that is claimed by a patent, to include a statement:
(1) that identifies the relevant patent and the approved use covered by the patent; and
(2) that the applicant is not seeking approval of such use. Requires the court to consider the totality of circumstances and the public interest in deciding whether to shorten the 30-month period that delays the approval of an abbreviated drug application when a patent infringement case is filed against the applicant. Limits market exclusivity provided for conducting pediatric studies of new or already approved drugs to only those drugs for which the Secretary of Health and Human Services approves labeling that provides specific, therapeutically meaningful information about the use of the drug in pediatric patients. Reduces market exclusivity for such studies for drugs with sales revenue that is $1 billion or more. Prohibits the Secretary from delaying approval of a new drug application while a petition seeking any action relating to such an application is being reviewed or considered. Requires the Secretary to take final agency action on a petition within 180 days of receipt, with no extensions allowed. Extends the 30-month period that the Secretary has to approve or disapprove an abbreviated application for a new drug by the amount of time that lapses from the date the Secretary receives a petition and the date of the final agency action on the petition, without regard to whether the Secretary grants or denies the petition.
...Read the Rest
Recent News Coverage
Hmmmm, no news coverage found for this bill at this time. This means that this this bill has not yet been mentioned on a publicly-searchable news website by either its official number (for example, "H.R. 3200") or title (for example, "America's Affordable Health Choices Act of 2009"). As soon as that changes, our daily automated search across the Web will catch it and include it here. If this bill is of interest to you, you can write a letter to the editor referring to this bill by name, and if your letter is published on the Web, a link back your letter will appear here within about one day. Or, if you know of a news article about this bill to display here, email us the web address of this page and the web address of your suggested news article: Our editorial team will post relevant links as quickly as possible. Thanks for helping to build public knowledge about Congress.
Recent Blog Coverage
S.1088: A bill to provide increased funding for the ... - OpenCongress
Official government data, breaking news and blog coverage, public comments and user community for S.1088 A bill to provide increased funding for the reinsurance for early retirees program.
Deutschland Archiv: Zeitschrift für das vereinigte Deutschland - H ...
Ulrich Mählert u. a. (Hg.): Jahrbuch für Historische Kommunismusforschung 2008 (Georg Wurzer) S. 1088. Vladislav M. Zubok: A Failed Empire (Hermann Wentker) S. 1089-1090. Silke Satjukow: Besatzer (Winfrid Halder) S. ...
Deutschland Archiv: Zeitschrift für das vereinigte Deutschland - H ...
Ulrich Mählert u. a. (Hg.): Jahrbuch für Historische Kommunismusforschung 2008 (Georg Wurzer) S. 1088. Vladislav M. Zubok: A Failed Empire (Hermann Wentker) S. 1089-1090. Silke Satjukow: Besatzer (Winfrid Halder) S. 1091-1093 ...
Vote on This Bill
-
Share This Bill
More Share via Email
